Cepmox: Potent Broad-Spectrum Antibiotic for Effective Bacterial Eradication
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.38 | $41.40 (0%) | 🛒 Add to cart |
| 60 | $0.72 | $82.80 $43.42 (48%) | 🛒 Add to cart |
| 90 | $0.54 | $124.20 $48.47 (61%) | 🛒 Add to cart |
| 120 | $0.46 | $165.60 $55.54 (66%) | 🛒 Add to cart |
| 180 | $0.40 | $248.40 $71.69 (71%) | 🛒 Add to cart |
| 270 | $0.36 | $372.61 $95.93 (74%) | 🛒 Add to cart |
| 360 | $0.32
Best per pill | $496.81 $116.12 (77%) | 🛒 Add to cart |
Cepmox (Amoxicillin and Clavulanic Acid) is a powerful, combination antibiotic formulation designed to combat a wide range of bacterial infections with enhanced efficacy. By synergistically combining a penicillin-class antibiotic with a beta-lactamase inhibitor, Cepmox effectively overcomes bacterial resistance mechanisms, ensuring targeted and reliable treatment outcomes. It is indicated for numerous common and complex infections, providing clinicians with a trusted therapeutic option backed by extensive clinical evidence and a well-established safety profile.
Features
- Contains Amoxicillin 500mg and Clavulanic Acid 125mg per tablet
- Broad-spectrum activity against Gram-positive and Gram-negative bacteria
- Beta-lactamase inhibitor protects amoxicillin from enzymatic degradation
- Available in both oral tablet and suspension formulations
- Manufactured under strict pharmaceutical quality control standards
- Rapid absorption and high tissue penetration
Benefits
- Effectively treats resistant bacterial strains that are unresponsive to amoxicillin alone
- Provides comprehensive coverage for mixed infections
- Reduces the risk of treatment failure and antibiotic resistance development
- Offers convenient twice-daily dosing for improved patient compliance
- Demonstrates excellent clinical success rates in respiratory, urinary, and skin infections
- Well-tolerated with a predictable safety profile in appropriate patient populations
Common use
Cepmox is commonly prescribed for bacterial infections including acute bacterial sinusitis, community-acquired pneumonia, acute otitis media, skin and soft tissue infections, urinary tract infections, and dental infections. It is particularly effective against beta-lactamase producing strains of Staphylococcus aureus, Haemophilus influenzae, Escherichia coli, and Klebsiella species. Medical professionals often select Cepmox when first-line antibiotics have proven ineffective or when dealing with suspected resistant organisms.
Dosage and direction
The recommended adult dosage is one tablet (500mg/125mg) every 12 hours or one tablet (875mg/125mg) every 12 hours for more severe infections. For children, the suspension form is recommended at 25mg/3.6mg/kg/day to 45mg/6.4mg/kg/day divided every 12 hours, depending on infection severity. Tablets should be taken at the start of a meal to enhance absorption and minimize gastrointestinal discomfort. Treatment duration typically ranges from 5 to 14 days depending on infection type and clinical response. Complete the full prescribed course even if symptoms improve earlier.
Precautions
Patients with mononucleosis may develop skin rash and should avoid Cepmox. Use with caution in patients with hepatic impairment due to clavulanate metabolism. Periodic assessment of renal, hepatic, and hematopoietic function is recommended during prolonged therapy. May cause antibiotic-associated colitis; discontinue if diarrhea develops. Use during pregnancy only if clearly needed and after careful risk-benefit assessment. Caution advised in elderly patients who may have reduced renal function.
Contraindications
Cepmox is contraindicated in patients with history of hypersensitivity to amoxicillin, clavulanic acid, other beta-lactam antibiotics, or any component of the formulation. Contraindicated in patients with history of Cepmox-associated cholestatic jaundice or hepatic dysfunction. Should not be used in patients with phenylketonuria (contains phenylalanine). Avoid in patients with severe renal impairment (creatinine clearance <30 mL/min) without appropriate dosage adjustment.
Possible side effect
Common side effects include diarrhea (9%), nausea (3%), vomiting (1%), and skin rashes (3%). Less frequently reported effects include vaginitis, abdominal discomfort, headache, and dizziness. Hepatic effects including transient rises in AST and ALT may occur. Rare but serious side effects include pseudomembranous colitis, hepatitis, cholestatic jaundice, Stevens-Johnson syndrome, and anaphylaxis. Hematologic effects such as thrombocytopenia, leukopenia, and agranulocytosis occur rarely.
Drug interaction
Probenecid decreases renal tubular secretion of amoxicillin, increasing blood levels. Concurrent use with allopurinol may increase incidence of skin rashes. May reduce efficacy of oral contraceptives; recommend additional contraceptive methods. Warfarin effects may be enhanced, requiring more frequent INR monitoring. Cepmox may reduce intestinal flora and decrease vitamin K synthesis, potentially enhancing anticoagulant activity. Concurrent use with bacteriostatic antibiotics may reduce Cepmox’s bactericidal effects.
Missed dose
If a dose is missed, take it as soon as remembered unless it’s almost time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintain regular dosing intervals to ensure consistent therapeutic blood levels. If multiple doses are missed, contact healthcare provider for guidance on resuming therapy. Consistent dosing is crucial for maintaining effective antibiotic concentrations and preventing resistance development.
Overdose
Symptoms may include gastrointestinal disturbances (nausea, vomiting, diarrhea), electrolyte imbalances, and renal impairment. Management involves symptomatic and supportive care. Maintain hydration and electrolyte balance. Hemodialysis may enhance elimination of both components. There is no specific antidote. In cases of significant overdose, monitor renal function and provide appropriate medical supervision. Contact poison control center or emergency department immediately for guidance.
Storage
Store at controlled room temperature (20-25°C or 68-77°F). Keep container tightly closed and protect from moisture. Dispense in original container. Oral suspension should be refrigerated after reconstitution and discarded after 10 days. Keep out of reach of children. Do not use after expiration date printed on packaging. Protect from excessive heat and light. Do not freeze the suspension formulation.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any medication. The prescribing physician should be aware of the patient’s complete medical history, current medications, and potential allergies. Dosage and treatment duration should be determined by a healthcare provider based on individual patient factors. Never share prescription medications with others.
Reviews
Clinical studies demonstrate Cepmox achieves clinical cure rates of 85-95% in approved indications. Physicians report high satisfaction with its efficacy in resistant infections. Patients appreciate the convenient twice-daily dosing and generally good tolerability. Some reviews note gastrointestinal side effects as the most common reason for discontinuation. Overall, it remains a first-choice antibiotic for many practitioners dealing with suspected resistant bacterial infections. Long-term clinical experience supports its position as a reliable combination antibiotic therapy.